Introduction
============

Epilepsy is part of a group of neurological disorders characterized by a long-term risk of recurrent unprovoked seizures ([@b1-etm-0-0-8742]). According to statistics from a meta-analysis, \>65 million people suffer from epilepsy worldwide ([@b2-etm-0-0-8742]). The majority of patients with epilepsy response well to anti-epileptic drugs, which control or reduce epileptic seizure occurrence. However, a number of patients gradually develop recurrent seizures and a resistance to anti-epileptic drugs ([@b3-etm-0-0-8742]). Further investigation is required to examine the underlying molecular mechanism of epilepsy and provide novel therapeutic approaches to fulfill clinical needs. Seizures are initiated by neuronal abnormality ([@b4-etm-0-0-8742]). Kainic acid (KA) is an agonist of kainite glutamate receptors and can induce their overstimulation, eventually leading to neuronal excitotoxicity and neuronal cell death ([@b5-etm-0-0-8742]). Therefore, KA is used in model systems to establish temporal lobe epilepsy, in order to study the mechanism and efficacy of drugs in epileptic seizures ([@b6-etm-0-0-8742]).

Inflammation processes have been clinically and experimentally reported to serve a pivotal role in the generation of seizures ([@b7-etm-0-0-8742],[@b8-etm-0-0-8742]). It was observed that inflammatory mediators are upregulated during the development of seizures in the mouse model ([@b9-etm-0-0-8742]). In patients with intractable epilepsy, the elevation of cytokines, including interleukin (IL)-1β was detected in the brain tissues ([@b10-etm-0-0-8742]). IL-1β blockers are therefore considered as a potential treatment approach for patients with epilepsy ([@b11-etm-0-0-8742]). Results from studies using KA model indicated that KA administration activated microglia and the release of several important cytokines, including tumor necrosis factor-α (TNF-α), IL-1β, IL-12 and IL-18 ([@b12-etm-0-0-8742]). IL-1β serves a key role in the recurrence of seizures by mediating enhanced calcium influx to induce proconvulsant effects ([@b16-etm-0-0-8742]).

Quercetin is derived from *Quercetum* (oaks) and is categorized as a flavonol ([@b17-etm-0-0-8742]). Previous studies suggested that quercetin shows anti-carcinogenic, anti-inflammatory, antiviral, antioxidant and psychostimulant activities ([@b17-etm-0-0-8742],[@b18-etm-0-0-8742]). For example, quercetin administration can decrease histological signs of acute inflammation in animals in a dose-dependent manner by inhibiting the release of chemokine and the lipid peroxidation end-product malondialdehyde, and increasing antioxidant enzyme activity ([@b19-etm-0-0-8742]). Quercetin also exhibits a neuro-protective function in several central nervous system disorders, including seizures and Huntington\'s disease ([@b20-etm-0-0-8742],[@b21-etm-0-0-8742]). Moghbelinejad *et al* ([@b22-etm-0-0-8742]) has suggested that quercetin regulated GABAA receptor α5, as well as β1 and β3, in a KA-induced seizure model of mice. However, the potential molecules regulated by quercetin in a KA-induced seizure remain to be investigated.

Materials and methods
=====================

### Mouse model

A total of 30 male BALB/c mice (weight 20-22 g; 8 weeks old) were purchased and housed in laboratory conditions (relative humidity of 45-55%, 12-h-light/dark cycle, freely available food and water) at room temperature of 20-23˚C. Experiments were carried out in accordance with the International Guidelines for Animal Studies regarding the care and use of animals for experimental purposes ([@b23-etm-0-0-8742]). The study was approved by the Ethics Committee of School of Life Science at the Jiangsu Normal University. KA and quercetin were bought from Sigma-Aldrich (Merck KGaA).

KA and quercetin were dissolved in saline (0.9% w/v) and Tween-80 (0.8% v/v), respectively. The mice were divided into three groups consisting of 10 mice per group. The control group was intraperitoneally administered with saline (10 µl, 0.9% w/v, i.p.) + Tween-80 (10 µl, 0.8% v/v, i.p.) daily for one week and on the last day they were injected with saline (10 µl, 0.9% w/v, i.p.) + Tween-80 (10 µl, 0.8% v/v, i.p.) followed by saline (10 µl, 0.9% w/v, i.p.) injection 30 min later. The mice in the KA group were injected daily with saline (10 µl, 0.9% w/v, i.p.) + Tween-80 (10 µl, 0.8% v/v, i.p.) for one week and on the last day, the mice were injected with saline, and KA (10 µl, 10 mg/kg, i.p.) was subsequently intraperitoneally administered. In the KA+quercetin group, the mice were intraperitoneally injected with quercetin (10 µl, 100 mg/kg, i.p.) daily for one week and on the last day, KA (10 µl, 10 mg/kg, i.p.) was administered 30 min following injection with quercetin (10 µl, 100 mg/kg, i.p.). Following injection of KA, mice were observed for behavioral changes over a period of 2 h. In accordance with a previous study, the behavioral tests were scored from 0-6 according to the following criteria: 0, No response; 1, immobility; 2, rigid posture; 3, scratching/circling/head bobbing; 4, forelimb clonus/rearing/falling; 5, repetitive pattern of 4; and 6, severe tonic-clonic seizures ([@b24-etm-0-0-8742]). Following observation, mice were deeply anesthetized with sodium pentobarbital (65 mg/kg, intraperitoneally) and sacriﬁced using cervical dislocation. The hippocampus of each mouse was collected, cleaned with chilled saline at 4˚C and frozen for subsequent experimentation.

### Primary glial cell culture

Experiments were carried out in accordance with the International Guidelines for Animal Studies regarding the care and use of animals for experimental purposes ([@b23-etm-0-0-8742]). The study was approved by the Ethics Committee of School of Life Science at the Jiangsu Normal University. Glial cells were derived from 20 postnatal day 1-3 BALB/c mice purchased from the Branch of National Breeder Center of Rodents. Briefly, 5 neonatal mice were rinsed in 70% ethanol, followed by a quick decapitation. Afterwards, cerebral cortices were isolated, meninges were removed and tissue was minced and incubated with trypsin (0.025%) for 15 min at 37˚C, followed with a trituration in the presence of DNAse I (50 µg/ml; Sigma-Aldrich; Merck KGaA) and 20% fetal bovine serum (FBS) in Ca^2+^-/Mg^2+^-free PBS. Cells were suspended in DMEM (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc.), 2 mM L-glutamine, 100 U/ml penicillin and 100 g/ml streptomycin, thereafter, cells (2x10^6^ cells/well) were seeded onto poly-L-ornithine coated 6-cm diameter Petri dishes and incubated in 95% humidity and 5% CO~2~ at 37˚C. After incubation for 14 days, microglia were collected by shaking the mixed glial cell cultures for 1 h. Thereafter, microglial cells (5x10^4^ cells/well) were seeded into 96-well plates and incubated in 95% humidity and 5% CO~2~ at 37˚C for 1 h, followed by the removal of non-adhering cells by washing the plates. The final purity of microglia cells was \~80%.

Isolated microglia cells were then placed in DMEM followed by treatment with saline + Tween-80 (control group) or KA alone (100 µM; KA group) or 100 µM KA preceded by 10 nM quercetin (KA+quercetin group). Treatment with quercetin was performed 30 min prior to KA treatment. Cells were treated with KA for 24 h then subjected to the following experiments.

### Western blot analysis

TNF-α (cat. no. 11948; 1:1,000), IL-1β (cat. no. 31202; 1:1,000) and NF-κB p65 (cat. no. 8242; 1:2,000) and phospho-p65 (p-p65; cat. no. 3031; 1:1,000) antibodies were purchased from Cell Signaling Technology, Inc. Ionized calcium-binding adapter molecule 1 (IBA1; cat. no. ab178846; 1:2,000) and GAPDH (cat. no. ab181602; 1:10,000) antibodies were purchased from Abcam. HRP-conjugated secondary antibodies anti-rabbit (cat. no. ab7083; 1:10,000) and anti-goat (cat. no. ab7125; 1:10,000) were purchased from Abcam. Hippocampi were dissected and snap frozen in liquid N~2~ for subsequent protein extraction. Proteins from tissues and cells were isolated with RIPA lysis buffer (Sigma-Aldrich; Merck KGaA). The concentration of protein lysates was determined by a bicinchoninic acid kit (Sigma-Aldrich; Merck KGaA). Equal amount of proteins (20 µg) were loaded and separated on an 8% SDS-PAGE gel. The proteins were transferred to a PVDF membrane, blocked by 5% non-fat milk at room temperature for 2 h and washed by TBST (TBS contained 0.1% Tween-20) for 3 times (10 min/time). The membranes were then incubated with primary antibodies at 4˚C overnight, washed by TBST for 3 times (10 min/time) and incubated with secondary antibodies at room temperature for 1 h, washed by TBST for 3 times (10 min/time), successively. The blots were developed with ECL Western Blot kit (Pierce; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. ImageJ software version 1.8.0 (National Institutes of Health) was used for densitometry analysis.

### ELISA

The microglia cells were collected by scraping before the removal of the culture medium. Cells were washed with cold phosphate buffer saline (PBS), re-suspended in Tris-Cl (10 mM; pH 7.4) and lysed in triplicate. Protein content in the culture medium was then analyzed by ELISA using the Quantikine TNF-α (cat. no. MTA00B) and IL-1β (cat. no. MLB00C) ELISA kit (R&D Systems, Inc.), according to the manufacturer\'s protocol.

### Statistical analysis

The experiment was repeated three times and all data were calculated by GraphPad Prism 6.0 (GraphPad Software, Inc.) and presented as mean ± standard deviation. Two groups were compared with unpaired Student\'s t-test. Three groups were firstly compared with one-way ANOVA followed by Newman Keuls analysis. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Quercetin attenuates KA-induced seizure score in mice

Compared with the control group, KA administration (10 mg/kg) successfully caused seizures with a significantly increased seizure score (P\<0.001, 4.82±0.44 vs. 0.08±0.04), which in turn was significantly reduced by quercetin administration (100 mg/kg) in the KA+quercetin group (P\<0.01, 3.83±0.18) ([Fig. 1](#f1-etm-0-0-8742){ref-type="fig"}). The results suggested the potential role of quercetin in relieving KA-induced epilepsy in mice.

### Quercetin attenuates KA-induced proinflammatory cytokine production in mice

The results of the western blot analysis showed that mice in the KA group (10 mg/kg) exhibited increased TNF-α (P\<0.001) and IL-1β (P\<0.01) protein expression levels, when compared with those of the control group. In addition, TNF-α (P\<0.01) and IL-1β (P\<0.05) protein levels were lower in mice treated with quercetin (100 mg/kg) in the KA+quercetin group, when compared with those in the KA group ([Fig. 2](#f2-etm-0-0-8742){ref-type="fig"}).

### Quercetin attenuates KA-induced activation of NF-κB in mice

The results of the western blot analysis showed that there was increased NF-κB phosphorylated (p)-p65 protein expression level in the KA group (P\<0.01, 10 mg/kg), when compared with the control group, which was subsequently significantly decreased by quercetin treatment (P\<0.05, 100 mg/kg). Meanwhile, there was no significant difference in NF-κB p65 protein expression level between the 3 groups ([Fig. 3](#f3-etm-0-0-8742){ref-type="fig"}).

### Quercetin attenuates KA-induced proinflammatory cytokine release from microglia cells

Results from the ELISA demonstrated that the culture medium of KA (P\<0.01, 100 µM)-treated microglia cells expressed significantly increased protein levels of TNF-α and IL-1β compared with those of the non-treated group. Furthermore, in the culture medium of microglia cells, which were pre-treated with quercetin (P\<0.05, 10 nM) prior to KA, TNF-α and IL-1β expression levels were significantly decreased compared with those of the KA group ([Fig. 4](#f4-etm-0-0-8742){ref-type="fig"}).

### Quercetin attenuates KA-induced activation of NF-κB and microglia cells

The results of the western blot analysis showed that compared with the control group, NF-κB p-p65 (P\<0.01) expression levels were increased in the KA (100 µM) group, which were decreased by quercetin treatment (P\<0.05, 10 nM). There was no significant difference of NF-κB p65 protein expression level among the 3 groups ([Fig. 5](#f5-etm-0-0-8742){ref-type="fig"}). In addition, compared with the control group, IBA1 (P\<0.001) expression levels were higher in the KA (100 µM) group, which were decreased by quercetin treatment (P\<0.01, 10 nM).

Discussion
==========

The functions of quercetin in animal models of seizures have been studied and its anticonvulsant properties have been indicated in rats and mice ([@b25-etm-0-0-8742]). In addition, clinical and experimental evidence has been reported, which indicates the association between epilepsy and inflammation ([@b28-etm-0-0-8742],[@b29-etm-0-0-8742]). In addition, quercetin has been reported to serve anti-inflammatory roles by inhibiting the expression of pro-inflammatory cytokines, such as TNF-α and IL-1β, in neurodegenerative diseases ([@b30-etm-0-0-8742]), including Parkinson\'s disease ([@b31-etm-0-0-8742]) and Alzheimer\'s disease ([@b32-etm-0-0-8742]). The aim of the present study was to investigate the potential therapeutic effects of quercetin and the underlying molecules that were regulated by quercetin in KA-induced epilepsy. The present study indicated that KA increased behavioral seizure activities and pro-inflammatory cytokines in the hippocampus of mice compared with the control group. However, quercetin decreased both of the aforementioned effects.

Neuroinflammation is characterized by the activation of microglia cells ([@b33-etm-0-0-8742]). Therefore, once activated, microglial cells take part in the inflammation process and facilitate the release of cytokines and chemokines, such as NF-κB, TNF-α and IL-1β ([@b34-etm-0-0-8742]). Quercetin inhibits the production of nitric oxide in BV2 microglial cells via NF-κB pathway inactivation ([@b35-etm-0-0-8742]). In addition, KA activates the NF-κB pathway prior to seizure occurrence ([@b36-etm-0-0-8742]).

Throughout the present study, in comparison with the control group, it was noted that KA increased TNF-α, IL-1β and NF-κB expression levels in the hippocampus of mice, and these were subsequently decreased with quercetin treatment.

KA has been reported to activate microglia cells in epilepsy ([@b37-etm-0-0-8742]). The aforementioned experiments were also repeated in microglia cells *in vitro*, in order to examine whether quercetin attenuates KA-induced epilepsy by inhibiting the activation of microglia cells. It was indicated that compared with the control group, there were higher TNF-α and IL-1β expression levels in the culture medium of microglia cells in the KA group, which were subsequently diminished by quercetin. Meanwhile, compared with the control group, there were higher NF-κB and IBA1 expression levels in microglia cells in the KA group, which were abolished by quercetin, indicating that it attenuates KA-induced epilepsy by inhibiting the activation of microglia cells.

In conclusion, the findings of the present study provide evidence on the role of quercetin in inhibiting KA-induced epilepsy by microglia cell inactivation and the production of NF-κB, TNF-α and IL-1β. These findings highlight the potential role of quercetin in the treatment of epilepsy.

However, there are two limitations of the present study: One is the lack of analysis of different quercetin doses, the other is the lack of *in vivo* and pathology experiments, these will be the subject of future studies.
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![Effects of quercetin (10 nM) on KA (100 µM)-induced NF-κB activation and IBA1 in microglia cells. (A) Western blotting and (B) quantification. ^\*\*^P\<0.01 and ^\*\*\*^P\<0.001 KA group vs. control group, ^\#^P\<0.05 and ^\#\#^P\<0.01 KA+quercetin group vs. KA group. n=6, results are collected from different time of repeats. KA, kainic acid; NF, nuclear factor; IBA1, ionized calcium-binding adapter molecule 1; p, phosphorylated.](etm-20-02-0854-g04){#f5-etm-0-0-8742}
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